A Phase I/II Trial of Crolibulin (EPC2407) Plus Cisplatin in Adults With Solid Tumors With a Focus on Anaplastic Thyroid Cancer (ATC)
Phase of Trial: Phase I/II
Latest Information Update: 12 Apr 2017
At a glance
- Drugs Crolibulin (Primary) ; Cisplatin
- Indications Solid tumours; Thyroid cancer
- Focus Adverse reactions; Therapeutic Use
- 27 Feb 2017 Status changed from active, no longer recruiting to completed.
- 30 Dec 2015 Number of treatment arms is increased from 3 to 5, according to ClinicalTrials.gov record.
- 07 Aug 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.